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Abstract
The pseudo-glycosyltransferase VldE catalyzes non-glycosidic C-N coupling between an unsaturated cyclitol and a saturated
aminocyclitol with the conservation of the stereochemical configuration of the substrates to form validoxylamine A 79-
phosphate, the biosynthetic precursor of the antibiotic validamycin A. To study the molecular basis of its mechanism, the
three-dimensional structures of VldE from Streptomyces hygroscopicus subsp. limoneus was determined in apo form, in
complex with GDP, in complex with GDP and validoxylamine A 79-phosphate, and in complex with GDP and trehalose. The
structure of VldE with the catalytic site in both an ‘‘open’’ and ‘‘closed’’ conformation is also described. With these
structures, the preferred binding of the guanine moiety by VldE, rather than the uracil moiety as seen in OtsA could be
explained. The elucidation of the VldE structure in complex with the entirety of its products provides insight into the
internal return mechanism by which catalysis occurs with a net retention of the stereochemical configuration of the
donated cyclitol.
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Introduction
Glycosyltransferases comprise one of the most numerous and
diverse groups of enzymes in nature. They are responsible for the
formation of oligo/polysaccharides, glycoproteins, glycolipids, and
many other glycosylated natural products by transferring a sugar
moiety from an activated donor sugar to a sugar (or non-sugar)
acceptor. This abundant group of proteins consists of 92 families
encoded by more than 83,400 genes [1]. However, only a fraction
of those genes has actually been functionally characterized. Our
comparative bioinformatics studies suggest that among those
reported as glycosyltransferases are also pseudo-glycosyltransfer-
ases (such as VldE, EC 2.x.x.x), which do not recognize sugars as
substrates but rather catalyze the formation of non-glycosidic C-N
bonds in the biosynthesis of C7N-aminocyclitol-containing natural
products such as acarbose and validamycin A (Figure 1) [2–4].
Acarbose, an a-glucosidase inhibitor, has been proven useful in the
treatment of type II insulin-independent diabetes, whereas
validamycin A, a natural trehalase inhibitor, is an antifungal
antibiotic that has long been used to protect crops from soil borne
diseases such as rice sheath blight and the dumping-off of
cucumber seedlings [5–8].
Validamycin A is a pseudo-trisaccharide whose structure is
comprised of validoxylamine A and glucose (Figure 1). The final
step in validamycin A biosynthesis is the attachment of glucose to
the precursory validoxylamine A by the action of the glycosyl-
transferase VldK (ValG) [2,9]. Validoxylamine A is generated
through the dephosphorylation of validoxylamine A 79-phosphate
by VldH while validoxylamine A 79-phosphate (VDO) results from
a condensation of GDP-valienol and validamine 7-phosphate
(both are pseudo-sugars) by the pseudo-glycosyltransferase, VldE
[3,4,10–14].
The mechanism by which non-glycosidic C-N bond is formed
by a pseudo-glycosyltransferase is not entirely understood.
However, because of the structural similarity of validoxylamine
A7 9-phosphate to trehalose 6-phosphate (Figure 1), it has been
speculated that the mechanism of the pseudo-glycosyltransferase
VldE is similar to that of the glycosyltransferase, trehalose 6-
phosphate synthase (OtsA, EC 2.4.1.15) [4]. VldE and Escherichia
coli OtsA only share a modest 19% sequence identity (29%
homology) (Figure 2), but they are both catalogued as members of
the GT20 glycosyltransferase family by the CAZy database (www.
cazy.org) [15]. OtsA mediates the transfer of glucose moiety from
UDP-glucose to glucose 6-phosphate to form trehalose 6-
phosphate (Figure 1). Similar to VldE, the product of OtsA
conserves the anomeric configuration of the donor moiety.
Glycosyltransferases have been shown to both retain and invert
the anomeric state of the carbon C-1 of the donor moiety. The
inversion of the anomeric center by glycosyltransferases has been
well explored and is known to be carried out by a simple
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mechanism of glycosyltransferases that retain the anomeric
configuration of the donated moiety within the product is not as
well understood. Catalysis by a retaining glycosyltransferases is
thought to occur through either a double displacement (SN2 X2)
or internal return mechanism (SNi) [16]. For a double displace-
ment nucleophilic substitution reaction to occur, a nucleophilic
catalytic base must be available in close vicinity to the sugar
anomeric carbon to form a covalent intermediate. OtsA
apparently lacks such a residue in the catalytic site and analyses
of theoretical energy profiles along with recent studies of kinetic
isotope effects have substantiated this unusual enzymatic reaction
mechanism within OtsA [17–19]. Lastly, structural studies of OtsA
using a bi-substrate inhibitor as a product mimic place the atoms
involved in catalysis in an orientation favorable for an internal
return mechanism and show that the leaving phosphate acts as a
general base to deprotonate the incoming nucleophile of the
acceptor group [20]. Within the SNi mechanism of OtsA, a
carbocation is developed upon the detachment of the nucleotide
phosphate which is stabilized by resonating into an oxonium ion-
like transition state [18,20]. However, no oxonium ion formation
is possible in the VldE-catalyzed non-glycosidic C-N coupling
reaction. Alternatively, it is proposed that the olefinic moiety of
GDP-valienol may play a critical role in facilitating the coupling
reaction [4]. Coupling reactions involving an allylic moiety have
been demonstrated in other biosynthetic enzymes, e.g., farnesyl
diphosphate (FPP) synthases [21,22]. However, in FPP synthases, a
nucleophilic substitution reaction takes place at a carbon center
with a diphosphate acting as a leaving group instead of nucleotidyl
diphosphate. In addition, mechanistically FPP synthases adopt a
stereospecific SN1 reaction with an inversion of the configuration,
leaving the actual mechanism behind the unique catalytic function
of the retaining VldE enzyme unclear. Hopefully, structural
studies would clarify whether or not a SNi mechanism is conserved
within the retaining pseudo-glycosyltransferase, VldE.
Here, we report the three-dimensional structures of VldE in
various liganded states using X-ray crystallographic techniques.
The structure of VldE was solved by molecular replacement using
the structure of OtsA as a search model. We have elucidated the
structures of the unliganded VldE, in complex with guanosine 59-
Figure 1. The VldE and OtsA Reactions. The product and substrates of the VldE and OtsA catalyzed reactions are shown. Note the considerable
similarity between the ligands of VldE and OtsA, and the conservation of the anomeric centers. The remainders of both biosynthetic pathways are
then drawn to completion. VldE catalyzes the formation of validoxylamine A 79-phosphate via a non-glycosidic C-N bond between GDP-valienol and
validamine 7-phosphate. After the validoxylamine A 79-phosphate has been produced; VldH and VldK complete the catalytic synthesis of Validamycin
A. OtsA catalyzes the formation of trehalose 6-phosphate via a glycosidic bond between UDP-glucose and glucose 6-phosphate. OtsB
dephosphorylates trehalose 6-phosphate to produce trehalose.
doi:10.1371/journal.pone.0044934.g001
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and in complex with GDP and VDO. Similar to OtsA, VldE is
comprised of two Rossman b/a/b domains which are oriented in
a GT-B configuration (Figure 3). The active site, which is located
at the interface of the Rossman domains, and the selective
interactions allowing for the binding of GDP but not uridine 59-
diphosphate (UDP) are described in our study (Figure 4A–B). The
crystallographic investigation of VldE while binding the complete
product complex, VDO and GDP, supports the proposed
conservation of a SNi catalytic mechanism analogous to the
mechanism of OtsA. Both the ‘‘open’’ and ‘‘closed’’ conformations
of the catalytic site are also described within this study.
Materials and Methods
Purification and Crystallization
VldE from S. hygroscopicus subsp. limoneus was expressed and
purified with methods similar to those previously described [4].
(His)6-tagged VldE was expressed in E. coli BL21 (DE3) pLysS and
was purified using Ni-NTA affinity chromatography. Affinity
Figure 2. An Sequence Alignment of VldE and OtsA. Shown is the protein sequence alignment of VldE and OtsA as generated by ClustalW2
[54]. Residues whose side-chains are involved in ligand binding are indicated with shaded boxes. Conserved residues are indicated with unfilled
boxes. The two-dimensional secondary structure of VldE and OtsA are also illustrated next to the corresponding sequence with a-helixes represented
by spirals and b-strands represented by arrows. Numerical values for helices and strands are assigned.
doi:10.1371/journal.pone.0044934.g002
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pH 7.5 with 300 mM NaCl, 20 mM imidazole, 5 mM b-
mercaptoethanol, and 10% glycerol. Elution from the Ni-NTA
resin was achieved using the same buffer but with 175 mM
imidazole. Using dialysis, the affinity chromatography buffer was
exchanged with VldE storage buffer consisting of 10 mM Tris-
HCl, pH 7.5 with 5% glycerol, 0.1 mM dithiothreitol, and 1 mM
MgCl2. VldE was concentrated to 10 mg/mL, and crystals were
grown using sitting drop vapor diffusion.
In the case of VldE and VldENGDP crystals, the mother liquor
consisted of 100 mM Tris-HCl, pH 8.0 with 30–35% polyethyl-
ene glycol 3,350. GDP, at a concentration of 3 mM, was added to
protein stocks which were intended to grow VldENGDP crystals by
co-crystallization. Crystals with a size of 0.160.160.5 mm were
grown over a period of four to twelve weeks. Crystallization took
place at a temperature of 293 K. Cryoprotectant solutions,
consisting of artificial mother liquor enriched with 20% ethylene
glycol, were added to crystal drops at a 1:1(v/v) ratio. In the case
of VldENGDP crystals, 5 mM GDP was added to the cryoprotec-
tant solution. Crystals were flash-cooled in liquid nitrogen after
soaking in the cryoprotectant solution for 20–40 minutes.
In the case of VldENGDPNVDO crystals, the mother liquor
consisted of 100 mM Tris-HCl, pH 8.0 with 25–30% polyethyl-
ene glycol 3,350. The drop was formed through a mixture of
mother liquor, protein, and seed stock in a ratio of 1.6:2.0:0.4 (v/
v). Seed stocks were prepared from crystal grown in similar
conditions using Seed Beads (Hampton Research) in a stabilization
buffer of 100 mM Tris-HCl, pH 8.0 with 31% polyethylene glycol
3,350. The Crystals with a size of 0.160.160.5 mm were grown
over a period of four to twelve weeks at a temperature of 293 K.
Cryoprotectant solutions, consisting of artificial mother liquor
enriched with 20% ethylene glycol, were added to crystal drops at
a 1:1(v/v) ratio. 5 mM GDP and 10 mM VDO were added to the
cryoprotectant solutions. Crystals were flash-cooled in liquid
nitrogen after soaking in the cryoprotectant solution for 20–40
minutes.
In the case of VldENGDPNTRE crystals, the mother liquor
consisted of 50 mM Tris-HCl, pH 8.0, 18–28% polyethylene
glycol 3,350, 200–500 mM NaCl, and 20 mM MgCl2. VldE was
kept at a concentration of 10 mg/mL, and crystals were grown
using sitting drop vapor diffusion with a 1:1(v/v) mixture of
protein and mother liquor. Before the drops were set, 3% trehalose
and 1 mM GDP were added to the protein stocks. The Crystals
with a size of 0.160.160.1 mm were grown over a period of four
to eight weeks at a temperature of 293 K. Cryoprotectant
solutions, consisting of reservoir solution enriched with 20%
ethylene glycol, 3% trehalose, and 1 mM GDP were added to
crystal drops at a 1:1(v/v) ratio. Crystals were flash-cooled in liquid
nitrogen after soaking in the cryoprotectant solution for 20–40
minutes.
Data Collection and Processing
All diffraction data except for the VldENGDP dataset was
collected at the Northeastern Collaborative Access Team (NE-
CAT) beamline at the Advanced Photon Source (Argonne
National Laboratory). Data was recorded at 100 K on an ADSC
Q315 (315 mm6315 mm) detector and processed by NE-CAT’s
RAPD automated processing (https://rapd.nec.aps.anl.gov/rapd),
which uses XDS [23] for integration and scaling. A 2.0 A ˚ VldE
dataset was collected at a wavelength of 0.9479 A ˚ while oscillating
the crystal 0.5 degrees for each frame. A 2.11 A ˚ VldENGDPNVDO
dataset was collected at a wavelength of 0.9792 A ˚ while oscillating
the crystal 1.0 degrees for each frame. A 2.81 A ˚ VldENGDPNTRE
dataset was collected at a wavelength 0.9792 A ˚ while oscillating
the crystal 1.0 degrees for each frame. The 2.15 A ˚ VldENGDP
dataset was collected at NSLS Beamline X6A at a wavelength
1.0 A ˚ while oscillating the crystal 1.0 degrees for each frame. X-
ray data was collected on a ADSC Quanta CCD detector at
100 K and was integrated, merged, and scaled using HKL2000
[24]. Although the cell dimensions were similar, the unliganded
VldE crystal belonged to the P2 space group, while the VldENGDP
and VldENGDPNVDO crystals belonged to the P21 space group.
Figure 3. The Overall Fold of VldE. Shown is the overall fold of VldE as well as comparison to OtsA by superimposition. (A) The overall fold of the
monomeric VldE is represented in a ribbon diagram. The monomer is rendered with the N-terminal domain in red, and the C-terminal domain in blue.
The a-helical C-terminus, which stretches back across both domains, is rendered in green. VldE consists of twin Rossman-like b/a/b domains in a GT-B
configuration with the catalytic site marked by VDO and GDP at the interface of the two domains. (B) To compare the overall fold of VldE (green) to
OtsA (gray), the folding patterns, which were represented by a tracing of C
a, were superimposed. (C) Shown is a topology diagram of VldE with b-
strands and a-helices labeled. Blue boxes identify the core b-sheets of the N- and C-terminal Rossman domains as well as the unique b-hairpin motif.
doi:10.1371/journal.pone.0044934.g003
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PLOS ONE | www.plosone.org 4 September 2012 | Volume 7 | Issue 9 | e44934Figure 4. The Catalytic Site of VldE. Shown is a comparison of the VldE and OtsA catalytic sites in ribbon diagrams. Residues/molecules of
interest are represented in stick models. The dotted lines mark hydrogen bonds and ionic interactions. The preferential binding of GDP by VldE is
demonstrated by comparing (A) the protein-ligand interactions within the VldE active site (green) with (B) the protein-ligand interactions between
OtsA and UDP within the OtsA active site (gray). The protein interactions with ribose and phosphate are conserved between VldE and OtsA. However,
there are differing interactions with the nucleotide base groups. The large purine makes interactions with the residues Arg321, Asn323, Asn361, and
Thr366. The ribose and phosphate moieties interact with Arg290, Lys295, Leu387, Ser388, and Glu391. Within OtsA, Leu344, Ile295, Pro297, and
His338 only allow for the binding of the smaller pyrimidine. The ribose and phosphate moieties make interactions with residues Arg262, Lys267,
Leu365, and Glu369. The mesh represents the |Fo| 2 |Fc| electron density omit map of the GDP binding site. The map is contoured at 3.0s levels. (C)
Shown is a superimposition of the VldE cyclitol binding sites in the presence (yellow) and absence (green) of validoxylamine A 79-phosphate. The
mesh represents the |Fo| 2 |Fc| electron density omit map of the VDO binding site. The map is contoured at 3.0s levels. VDO makes interactions with
residues the side-chains of residues Asp158, His182, Arg12, Asn325, Arg326, and Asp383. VDO also makes interactions with the backbones of residues
384–387. Binding of the acceptor cyclitol is recognized by conformation changes by the side-chains of residues Asp158, Tyr159, and Arg326. (D)
Shown is a comparison by superimposition of VDO binding within the catalytic sites of VldE (yellow) and OtsA (gray). Note the strong conservation of
residue and ligand positions.
doi:10.1371/journal.pone.0044934.g004
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dissimilar and belonged to the C2 space group. Diffraction data
statistics are summarized in Table 1.
Structure Determination and Refinement
To determine the structure of VldE, molecular replacement
(MR) was performed. Generation of a search model from the OtsA
structure (PDB accession code 1UQU [25]) and molecular
replacement was carried out using MrBUMP [26] to orchestrate
molecular replacement via the MOLREP [27] module in the
CCP4 [28] program suite. The resulting MR model was used to
build a partially sequenced model (,400 residues) using the
AUTOBUILD [29–32] function of the PHENIX [33] software
suite. Further automated model building was carried out using the
ARP/wARP [34] module within the CCP4 [28] software suite.
The model was finished by manual building within COOT [35].
The model was refined using restrained refinement by REFMAC5
[36] with TLS parameters defined by the TLSMD server [37,38].
Two monomers were modeled within the asymmetric unit, and
non-crystallographic symmetry (NCS) restraints were used during
refinement. Waters were incorporated into the models by referring
to the |Fo| 2 |Fc| omit maps. Out of the possible 994 residues,
957 residues were modeled with 97.8% within the most favored
regions of the Ramachandran plot. Although 0.5% are reported as
outliers, they are all within well-defined electron densities. The
final model, which lacked residues 1, 2, and 482–497, has a Rwork
of 0.190 and an Rfree of 0.222. The structure refinement statistics
are summarized in Table 1.
The VldENGDP, VldENGDPNVDO, and VldENGDPNTRE
structures were solved using the unliganded VldE structure as a
search model within the AUTOMR [39] function of the PHENIX
[33] software suite. The models were finished by manual building
within COOT [35]. The models was refined the PHENIX.RE-
FINE [29] function of the PHENIX [33] software suite. Ligands
and waters were incorporated into the models by referring to the
|Fo| 2 |Fc| omit maps. Two monomers were modeled within
the VldENGDP the asymmetric unit, six monomers were modeled
within the VldENGDPNTRE the asymmetric unit, and two
Table 1. Statistics of reflection data and structure refinements.
Liganding VldE VldENGDP VldENGDPNVDO VldENGDPNTRE
Space Group P2 P21 P21 C2
Unit Cell Dimension (A ˚) 84.75, 48.43, 47.82, 121.15, 47.96, 120.71, 320.82, 122.82,
122.66 84.33 84.24 93.86
Unit Cell b-angles(u) 91.88 91.74 91.63 91.62
Wilson Plot B Value (A ˚2) 48.74 35.96 40.37 53.40
Resolution Range (A ˚) 48.92–1.95 37.52–2.15 47.94–2.11 49.15–2.81
Reflections Observed 245,918 368,911 205,530 220,052
Unique Reflections 69,317 51,924 55,049 88,243
Reflections Rfree Set 3,559 2,645 2,790 4,421
Completeness (%) 98.1 (91.8) 99.9 (100.0) 99.7 (99.0) 99.3 (98.5)
Redundancy 3.5 (3.3) 7.1 (7.1) 3.7 (3.7) 2.5 (2.5)
,I/s. 13.0 (2.7) 25.2 (3.1) 16.5 (2.7) 12.2 (2.7)
Rsym 0.045 (0.421) 0.078(0.522) 0.049(0.433) 0.058(0.304)
Rwork 0.190 0.197 0.191 0.211
Rfree 0.222 0.209 0.222 0.258
No. TLS Bodies 6 n/a n/a n/a
No. of Amino Acids 957 948 950 2,738
No. of Protein Atoms 7,474 7,378 7,361 21,796
No. of Hetero Atoms 0 58 120 214
No. of Waters 492 405 488 202
RMSD Bond Lengths (A ˚) 0.022 0.012 0.017 0.016
Angles (u) 1.67 1.30 1.76 1.47
Mean B Factor 41.85 40.21 39.62 62.41
Protein Atoms (A ˚2) 42.63 40.19 39.59 62.61
Hetero Atoms (A ˚2) n/a 34.34 37.63 62.57
Water Atoms (A ˚2) 29.38 40.93 40.50 40.82
Ramachandran Outliers (%) 0.5 0.4 0.4 0.4
Ramachandran Favored (%) 97.8 97.8 97.3 95.5
Poor Rotamers (%) 1.6 1.3 1.6 1.5
Rsym=S h(S j|Ihj 2, Ih.|/S Ih,j), where h=set of Miller indices, j=set of observations of reflection h,a n d,Ih.=the mean intensity. RMSD values are deviation from ideal
values. Rcrys= Sh||Fo,h|–| F c,h||/Sh|Fo,h|. Rfree was calculated using 5% of the complete data set excluded from refinement. The numbers in parentheses represent values
from the highest resolution shell (2.08–2.00 A ˚ for VldE, 2.23–2.15 A ˚ for VldENGDP, 2.22–2.11 A ˚ for VldENGDPNVDO, and 2.96–2.81 A ˚ for VldENGDPNTRE).
doi:10.1371/journal.pone.0044934.t001
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asymmetric unit. NCS restraints were used during all refinements.
In these structures, 0.4% of residues are reported as Ramachan-
dran outliers; however, they are all within well-defined electron
densities, and outliers at residues Asp158 and Asn386 were
common within all the monomers of all the models of VldE.
Diffraction and structure refinement statistics are summarized
in Table 1. Coordinates and structure factors have been deposited
in the Protein Data Bank with accession numbers: VldE (PDB ID:
3VDM), VldENGDP (PDB ID: 4F96), VldENGDPNVDO (PDB ID:
4F97), and VldENGDPNTRE (PDB ID: 4F9F).
Results
Overall Structure
As was described in a recent crystallographic study of ValL [40],
a VldE homolog from S. hygroscopicus subsp. jinganggensis, VldE is a
homodimer. Each monomer consists of twin Rossman b/a/b
domains in the GT-B configuration [41] (Figure 3A) with the
terminal helix (a16) extending back across the C-terminal
Rossman-like domain to reach the N-terminal Rossman-like
domain with a turn at Trp458 as it crosses the interface of the
two domains. Despite a modest 19% sequence identity (29%
homology) (Figure 2), the overall fold of VldE is remarkably similar
Figure 5. Ligand Interactions. Shown in this figure is the hydrogen bond network between VldE and (A) GDP and then (B) VDO.
doi:10.1371/journal.pone.0044934.g005
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the previous study [40] however, the core of the N-terminal
domain of our apo enzyme is found with the catalytic site in an
‘‘open’’ conformation instead of ‘‘closed’’. In this ‘‘open’’
conformation, the core b-sheet of the N-terminal Rossman-like
domain consists of only ten strands instead of twelve. Two strands
described as part of the core sheet in the previous study now are
observed in a unique b-hairpin motif (b2 and b3) extending away
from the catalytic site. Simultaneously, there is a dramatic shift of
residues 33–47 away from the catalytic center. Unfortunately,
coordinates from the structural study of ValL were not publicly
available at the time of this study, so a complete comparison could
not be performed. However, the closed conformation of VldE will
Table 2. Notable interactions between VldE and ligands.
GDP Validoxylamine A Trehalose
79-Phosphate
Protein Atom Guanine Ribose 59- Donor Acceptor Donor Acceptor
phosphate Cyclitol Cyclitol-P Sugar Sugar
Arg321* NH2 O6 (3.3)
Asn323* ND2 N1 (3.3)
ND2 N2 (3.4)
Asp360 O O6 (3.3)
Asn361 OD1 N1 (2.6)
OD1 N2 (2.9)
Asp362 N O6 (2.9)
O O6 (3.2)
Thr366* OG1 N7 (2.6)
OG1 O6 (3.6)
Arg290 NE O2B (2.8)
NH2 O1B (2.9)
Lys295 NZ O3A (3.1)
NZ O1B (3.0)
Leu387 N O1A (3.4)
N O2A (2.8)
Ser388 OG O1A (2.6)
N O1A (3.1)
Glu391 OE1 O2’ (2.5)
OE2 O3’ (2.6)
His182 ND1 OAQ (2.8) O6P (3.7)
Asp383 OD1 OAS (2.9) O3P (3.3)
Gly384 N OAS (3.0) O3P (2.6)
Gln385 N OAS (2.7) O3P (2.2)
N OAR (2.8) O4P (3.2)
Asn386 N OAS (3.4) O3P (3.4)
N OAR (2.7) O4P (2.6)
Leu387 N OAR (3.6) O4P (3.7)
Asp158 OD1 OAO (3.3)
OD2 OAP (2.3)
Asn325 ND2 OAX (2.4)
ND2 OAY (2.7)
Arg326 NH1 OAW (3.0)
NE OAY (3.6)
Arg290 NE O4 (3.7)
Values in parentheses are distances given in angstroms.
Donor/Acceptor is an indicator of relative position within the catalytic site.
Distances describing GDP interactions with VldE are taken from the VldENGDP model.
*Indicates residues not conserved in OtsA that make guanine specific interactions.
doi:10.1371/journal.pone.0044934.t002
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experimental data.
The GDP bound structure of VldE (VldENGDP) described here
is also in an ‘‘open’’ conformation and the binding of GDP did not
have an effect on the global conformation of the apo enzyme
(RMSD C
a=0.350 A ˚). Surprisingly, the structure of VldE in
complex with the entirety of its products (VldENGDPNVDO), GDP
and VDO was also in an open conformation and a comparison to
the VldENGDP model showed that the binding of VDO also did
not have an effect of the global conformation of VldE (RMSD
C
a=0.262 A ˚).
Lastly, we were also elucidated the structure of VldE in complex
with both GDP and TRE (VldENGDPNTRE). Within the
VldENGDPNTRE structure, six monomers were modeled within
the asymmetric unit (ASU). The six monomers of the ASU
assumed three alternative conformers. The monomers of the first
conformation contained both GDP and trehalose, and this first
conformer was found to also have an ‘‘open’’ catalytic site with
similar global conformation to the VldENGDPNVDO complex
(RMSD C
a=0.705 A ˚). The last two conformers within the
VldENGDPNTRE structure had GDP but not trehalose bound,
and these two conformers contained a ‘‘closed’’ catalytic site as
described in the previous studies [40]. These alternative confor-
mations are significantly different when compared the ‘‘open’’
VldENGDP structure (RMSD C
a=2.304 A ˚, RMSD C
a=2.395 A ˚)
and are further discussed in later sections.
The Nucleotide Binding Site
Due to the conservation of key residues within their binding
pockets, the binding of ligands within VldE are thought to be
analogous to OtsA [19]. Here we provided experimental support
for the analogous binding of GDP within VldE and UDP within
OtsA. (Figure 4A) Within VldE, the ribose and phosphate moieties
of GDP make interactions with the side-chains of the residues
Arg290, Lys 295 and Glu391; as well as with the backbone atoms
of residues Leu387 and Ser388 (Figure 5A). These interactions are
conserved within OtsA (Figure 4B). The a-phosphate of GDP does
make a single unique interaction with Ser388 within VldE. This
interaction is not possible within OtsA as there is a valine at the
same position. Nonetheless, the ribose and phosphate moieties of
GDP within the VldE catalytic pocket are nearly superimposable
(RMSD=0.868) onto the ribose and phosphate moieties of UDP
within the OtsA catalytic pocket. The conserved position of the b-
phosphate of GDP is critically important because the bond
between this phosphate and the donated cyclitol is broken during
the transfer to the acceptor. As will be described later in this study,
the b-phosphate of GDP maintains an interaction with the
formerly bound carbon of validoxylamine A 79-phosphate in the
complete product complex (VldENGDPNVDO). This interaction is
similarly found within OtsA and similarly provides strong evidence
in support of an SNi mechanism [18].
The guanine moiety within the VldENGDP complex makes
interactions with the hydrophilic residues Arg321, Asn323, and
Thr366 (Figure 5A). The preference of a GDP activated donor
sugar by VldE (instead of UDP) is immediately apparent when
comparing the catalytic site to that of OtsA. The preference of
guanine by VldE is mediated by these three hydrophilic residues,
while the preference for a uracil moiety is mediated by three
hydrophobic residues at the same positions. Within OtsA, the
uracil is surrounded by the hydrophobic residues Ile295, Pro297,
and Leu344. This small hydrophobic binding pocket facilitates the
Figure 6. Trehalose within the Catalytic Site. Shown is a trehalose (TRE) within the VldE cyclitol binding site in ribbon diagrams. Residues/
molecules of interest are represented in stick models. The dotted lines mark hydrogen bonds. (A) The mesh represents the |Fo|2|Fc| electron density
omit map of trehalose within the VldE catalytic site (pink). The map is contoured at 3.0s levels. Trehalose makes interactions with the backbone
amides of residues Gly384, Gln385, Asn386, and Leu387 as well with the side-chains of Asp383, His182 and Arg290. (B) Shown is a superimposition of
the catalytic sites of VldE?GDP?VDO model (yellow) and the VldE?GDP?TRE model (pink) in ribbon diagrams. Trehalose does not assume a binding
pose comparable to VDO. This is most likely to do the absence of a phosphoryl group. Due to the absence of the phosphate moiety, Arg326 and
Asn325 also swing out of the catalytic site.
doi:10.1371/journal.pone.0044934.g006
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PLOS ONE | www.plosone.org 9 September 2012 | Volume 7 | Issue 9 | e44934Figure 7. Conformational Changes. Shown are ribbon diagrams of the three conformers of VldE modeled using the VldE?GDP?TRE
crystallographic data. Residues/molecules of interest are represented in stick models. Arrows indicate the direction of residue movement. Ligands
bound within each conformer are shown to provide a point of reference for comparison. (A) The global conformation of each conformer (gray) is
shown with the areas of conformational change highlighted by coloring (pink, blue, cyan). (B) Residues 11–50 for each conformer is shown. Note that
this region of residues is capable of 10.9 A ˚ shift towards the catalytic center and that strands of the b-hairpin motif (b2 and b3) move simultaneously
with strands b6 and b5 to extend the core b-sheet from ten to twelve strands. (C) A view of helix a3 for each conformer is shown. Note that residues
at the kink of the helix are capable of reorganizing.
doi:10.1371/journal.pone.0044934.g007
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are summarized in Table 2.
Cyclitol Binding Sites
The first crystallographic structure of VldE in complex with the
entirety of its products, VDO and GDP, was elucidated
(Figure 4C). The interactions between GDP and VldE are
described within the previous section, but here the interactions
between VDO and VldE are shown to be analogous to the
interactions previously described by the OtsANVDO complex [20].
The hydroxyls of the donated cyclitol make numerous interactions
with the backbone amides of VldE at residues Gly384, Gln385,
Asn386, and Leu387. The donated cyclitol also makes interactions
with the side-chains of residues His182 and Asp383 (Figure 5B).
The interactions by donated cyclitol are conserved within the
catalytic site of OtsA (Figure 4D). Also conserved is the interaction
of the b-phosphate with the formerly bound carbon of the donated
cyclitol. As in OtsA, the phosphate of the leaving nucleotide is
involved in the stabilization of the transition state during the
concerted, front-faced nucleophilic attack of a SNi reaction, and at
a distance of 2.6 A ˚ from the attacking nucleophile, the phosphate
can act as a general base to deprotonate the amine [20].
The binding of the acceptor cyclitol within VldE is recognized
by a shift in side-chain conformations within the catalytic site.
Asp158 swings 62–83u towards the catalytic center in recognition
of the hydroxyls of the acceptor cyclitol. Upon the binding of the
phosphorylated acceptor group, the guanidine moiety of Arg326
enters into an interaction with the phosphate oxygens. This
interaction allows Tyr159 to swing 110–112u to make an
interaction with Arg326. The acceptor cyclitol also interacts with
the side-chain of Asn325. These interactions are conserved within
OtsA except at Asn325. At the same position within OtsA there is
Ser299 which does not make an interaction with VDO (Figure 4D)
[4].
Despite the conservation of the interactions between the
catalytic site and VDO, there is no observed conformational
closing of the catalytic site upon the binding of the acceptor
cyclitol as was witnessed in structural studies of OtsA [19,20,25].
However, a closed conformation was described in the recently
published structural studies of ValL [40]. In later sections, such a
conformational shift will be described within our structural studies
of VldE, but this shift was not triggered by the binding of the
acceptor cyclitol.
Figure 8. The SNi mechanism of VldE. Shown is a figure comparing the SNi mechanism of (A) OtsA to the proposed SNi mechanism of (B) VldE.
The olefinic moiety of GDP-valienol plays a critical role in facilitating the coupling reaction through a mechanism similar to the formation of an
oxonium ion-like transition state upon the detachment of the nucleotide phosphate within OtsA. Both transition states are formed by the
coordination of the allylic carbon on the donated group, the bridging nucleophile of the acceptor group and the leaving oxygen of the donor
diphosphate-nucleotide.
doi:10.1371/journal.pone.0044934.g008
Table 3. DALI Server Results.
Enzyme Name RMSD
Trehalose-Phosphate Synthase (OtsA) 2.4
N-Acetyl-a-D-Glucosaminyl L-Malate Synthase
(BaBshA)
2.9
3-Phospho-1-D-I-Inosityl-2-Acetamido-2-Deoxy-a-
D-Glucopyranoside Synthase (MshA)
3.7
Trehalose Synthase (TreT) 3.1
Phosphatidylinositol Mannosyltransferase (PimA) 3.1
Glycogen Synthase (GlgA) 3.1
-Listed in order of DALI ranking.
doi:10.1371/journal.pone.0044934.t003
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both GDP and trehalose (VldENGDPNTRE). (Figure 6A) Within
this model, GDP maintains the interactions previously described
elsewhere within this study. The binding pose of trehalose is
similar to what was described by the recent structural study of
VldE [40]. The sugar moiety of trehalose within donor cyclitol
binding site makes interactions with the backbone amides of
residues Gly384, Gln385, Asn386, and Leu387 as well with the
side-chains of Asp383 and His182. Unsurprisingly, this preserves
the interactions between the enzyme and the structurally similar
donor cyclitol as was described in the VldENGDPNVDO model.
However, the sugar moiety of trehalose occupying the acceptor
cyclitol binding site makes only a single hydrogen bond with
Arg290 in our study. A superimposition of trehalose and VDO
within the VldE catalytic site shows that trehalose does not assume
a binding pose comparable to VDO (Figure 6B). This is most likely
due to the absence of a phosphorylated ligand. Within the
VldENGDPNVDO model, Arg326 and Asn325 interact with the
phosphorylated cyclitol and most likely help to ensure the proper
position of validamine 7-phosphate for catalysis. Indicatively,
Arg326 and Asn325 swing out of the catalytic site within our
trehalose bound structure. Interactions between VldE and VDO
and TRE are summarized in Table 2.
Observed Changes in Conformation
While solving the VldENGDPNTRE structure, six monomers of
VldE were placed within the asymmetric unit. Represented within
the six monomers were three differing conformations of the N-
terminal Rossman-like domain (two monomers per conformation)
(Figure 7A). However, no interesting conclusions regarding
possible allosteric interactions in this enzyme could be derived
from these observations alone.
The first conformer had GDP and trehalose bound and is
described in the previous section. This conformer is quite similar
to the other models with ‘‘open’’ catalytic sites expect for residues
325–328 which swing out of the catalytic site upon the binding of
trehalose. The second and third conformers have only GDP within
the catalytic site and both of these conformers share a dramatic
shift in residues 11–50 which result in the ‘‘closing’’ of the catalytic
site (Figure 7B). Resultantly, Gly33, Gly34, and Thr35 move
10.9 A ˚ towards the catalytic center, and within 4 A ˚ of the ligand
atoms. Additionally, helix a1, which originally consisted of
residues 36–41, coils further to include residues 42–47. This shift
occurs concurrently with the rotation of the b-hairpin motif (b2
and b3) unique to VldE. Additionally, the last two of ten strands
(b6 and b5) comprising the core b-sheet of the N-terminal
Rossman-like b/a/b domain move towards the compacting
catalytic site. The movements of the unique b-hairpin motif and
the two strands of the core b-sheet narrow the distance between
them and allow the necessary interactions to unite them into a
single twelve-stranded core b-sheet. The ‘‘closed’’ conformation
described here is similar to what was described in the structural
study of ValL. [40].
A conformational change which resulted in the closing of the
catalytic site was described within the structural studies of OtsA.
Residues were observed to make a .10 A ˚ movement towards the
catalytic center upon binding of the accepting sugar in OtsA
[19,25]. The conformational shift was thought to be due to the
recognition of the phosphate moiety of the accepting glucose 6-
phosphate by Arg9. However, with the lack of an acceptor group
within the catalytic site, the conserved arginine at position 12 of
VldE cannot be responsible for the closing of the catalytic site.
Therefore, the closing of the VldE catalytic site is more likely to
work at least partially through a more dynamic, equilibrium based
mechanism.
An additional conformation change was also observed within
the third conformer found within the VldENGDPNTRE crystal
(Figure 7C). Within the a3, there is a kink at residues 96–102.
Within the third conformer, the kinked residues shift to form a
more organized secondary structure. Again, the observed confor-
mational change is not concerted with the binding of ligand and
further supports the notion that VldE moves through equilibrium
based conformations. Conformational change at this position was
observed in the previous structural studies, and similarly the
change seems to be focused around Gln96 [40].
Discussion
Mechanistic Considerations
The net retention of the substrate stereochemistry is thought to
occur through either a double displacement (SN2 X2) or internal
return mechanism (SNi) [16]. Recent evidence substantiates claims
that the conservation of the anomeric center configuration within
OtsA is due to an internal return mechanism [18,20]. If the
reaction of VldE were to alternatively go through a double
displacement nucleophilic substitution mechanism, a residue must
be available to make a covalent intermediate. Comparatively, the
hydrolysis of glycosides is known to occur through a nucleophilic
substitution involving a covalent intermediate [42,43]. The most
likely candidate residue within VldE would be a nucleophilic
His182. As can be seen in Figure 4D, this residue is also conserved
within the catalytic site of OtsA (His154). At a 5.1 A ˚ from the
stereochemical center of the substrate, His182 is not observed to
be immediately available for nucleophilic substitution in our
structural studies, and as of yet there has been no significant, direct
evidence to support a mechanism by which the non-glycosidic
coupling reaction of VldE occurs through a covalent intermediate.
Our structural evidence demonstrates a strict conservation of
nucleotide and (pseudo)sugar orientation within VldE and OtsA
and suggests that the glycosyltransferase reaction of OtsA and the
pseudo-glycosyltransferase reaction of VldE do occur through
similar, concerted but asynchronous internal return mechanisms.
Therefore, the olefinic moiety of GDP-valienol must play a critical
role in facilitating the coupling reaction through a mechanism
similar to the formation of an oxonium ion-like transition state
upon the detachment of the nucleotide phosphate within OtsA as
was previously suggested [4]. Through such a mechanism, the
transition state is formed by the simultaneous binding of the allylic
carbon on donated cyclitol, the bridging amine of the acceptor
cyclitol-phosphate and the leaving oxygen of the donor diphos-
phate-nucleotide. As in OtsA [20], the leaving phosphate is in a
position to deprotonate the incoming nucleophile of the acceptor
cyclitol (Figure 8A–B).
Supportively, a distance matrix search using DALI [44]
revealed a strong similarity between VldE and OtsA, N-Acetyl-
a-D-Glucosaminyl L-Malate Synthase (BaBshA, EC 2.4.1.x), 3-
Phospho-1-D-I-Inosityl-2-Acetamido-2-Deoxy-a-D-Glucopyrano-
side Synthase (MshA, EC 2.4.1.250), Trehalose Synthase (TreT,
EC 2.4.1.245), Phosphatidylinositol Mannosyltransferase (PimA,
EC 2.4.1.57), and Glycogen Synthase (GlgA, EC 2.4.1.11)
(Table 3). All are retaining glycosyltransferases that have been
associated with internal return mechanisms [20,45–49] (Table 3).
Significance
The biosynthetic pathways of natural products exhibiting
antibiotic-like properties have recently become of great interest.
As seen in the discovery of the antibacterial erythromycin, the
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genetic manipulation of biosynthetic gene clusters along with the
use of alternative biosynthetic precursors, and recombinant
proteins for chemoenzymatic synthesis can result in the generation
of an entire array of biologically active compounds [50–53]. The
gene cluster responsible for the biosynthesis of validamycin A has
only been recently discovered, this study and others are underway
to elucidate the individual processes within this biosynthetic
pathway of this C7N-aminocyclitol [2].
The C7N-aminocyclitols (e.g., acarbose, validamycin, cetonia-
cytone, and salbostatin) belong to a class of natural products which
include the aminoglycosides (e.g., streptomycin, hygromycin,
butirosin, and neomycin), and the five membered aminocyclitols
or cyclopentitols (e.g., pactamycin, trehazolin, and allosamidin).
The aminoglycosides are a diverse group of natural products
which were amongst the first clinical antibiotics. The C7N-
aminocyclitols are an even more diverse group of natural products
with an entire range of biological activities [10]. A better
understanding of the biosynthesis of C7N-aminocyclitols at the
molecular level could allow for the generation of novel, natural
product analogs which could include an array of structurally
altered antibiotics. The line of inquiry provided within this article
hopes to add to that understanding.
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